Lan‐Ping Xu

15.6k total citations · 2 hit papers
608 papers, 10.2k citations indexed

About

Lan‐Ping Xu is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Lan‐Ping Xu has authored 608 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 478 papers in Hematology, 177 papers in Immunology and 150 papers in Oncology. Recurrent topics in Lan‐Ping Xu's work include Hematopoietic Stem Cell Transplantation (376 papers), Acute Myeloid Leukemia Research (195 papers) and Acute Lymphoblastic Leukemia research (133 papers). Lan‐Ping Xu is often cited by papers focused on Hematopoietic Stem Cell Transplantation (376 papers), Acute Myeloid Leukemia Research (195 papers) and Acute Lymphoblastic Leukemia research (133 papers). Lan‐Ping Xu collaborates with scholars based in China, United States and United Kingdom. Lan‐Ping Xu's co-authors include Xiao‐Jun Huang, Kai‐Yan Liu, Yu Wang, Xiaohui Zhang, Yu‐Hong Chen, Dai‐Hong Liu, Huan Chen, Ying‐Jun Chang, Chen‐Hua Yan and Xiao‐Dong Mo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Lan‐Ping Xu

557 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

2015 336 citations Yu Wang, Qifa Liu et al. Blood profile →
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

2021 150 citations Xiaohui Zhang, Qifa Liu et al. profile →

Peers

Countries citing papers authored by Lan‐Ping Xu

Since Specialization

Citations

This map shows the geographic impact of Lan‐Ping Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan‐Ping Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan‐Ping Xu more than expected).

Fields of papers citing papers by Lan‐Ping Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan‐Ping Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan‐Ping Xu. The network helps show where Lan‐Ping Xu may publish in the future.

Co-authorship network of co-authors of Lan‐Ping Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Lan‐Ping Xu. A scholar is included among the top collaborators of Lan‐Ping Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan‐Ping Xu. Lan‐Ping Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prognostic value of CEBPA bZIP signatures in cytogenetically normal acute myeloid leukaemia 2025 ·British Journal of Haematology ·Lixin Wu, (unknown), (unknown), (unknown), (unknown), Lixia Liu, (unknown), Shanbo Cao, Feng Jia, Qian Jiang, Ying‐Jun Chang, Lan‐Ping Xu, Xiaohui Zhang, Xiao‐Jun Huang, Hao Jiang, Hongyu Zhang, Guo‐Rui Ruan	0
2	Haploidentical hematopoietic stem cell transplantation with busulfan, cyclophosphamide, and fludarabine conditioning for X‐linked adrenal cerebral leukodystrophy 2024 ·Pediatric Transplantation ·Yao Chen, Lan‐Ping Xu, Xiaohui Zhang, Huan Chen, Kai‐Yan Liu, (unknown), Yanling Yang, Xiao‐Jun Huang	0
3	Letermovir prophylaxis for cytomegalovirus is associated with risk of post-transplant lymphoproliferative disorders after haploidentical stem cell transplantation 2024 ·Haematologica ·Xuying Pei, Qiang Huang, (unknown), (unknown), (unknown), Yuqian Sun, Xiao‐Dong Mo, (unknown), (unknown), Hongyan Ma, (unknown), Lan‐Ping Xu, Yu Wang, Xiaohui Zhang, Liang Chen, Xiao‐Jun Huang	4
4	The clinical outcomes of haploidentical stem cell transplantation (haplo-HSCT) for patients with therapy-related myelodysplastic syndrome: comparable to de novo myelodysplastic syndrome 2024 ·Clinical and Experimental Medicine ·Feifei Tang, Yunqi Wang, Yu Wang, Jian Jin, Wei Han, Yu‐Hong Chen, Chen‐Hua Yan, Lan‐Ping Xu, Xiaohui Zhang, Xiao‐Jun Huang	1
5	Cytology or Multiparameter Flow Cytometry Positivity in the Cerebrospinal Fluid Before Transplantation is Predictive of Poor Outcomes After Allotransplantation in Acute Myeloid Leukemia Patients 2024 ·Clinical Transplantation ·(unknown), (unknown), Yuanyuan Zhang, Yazhe Wang, Ya‐Zhen Qin, Yue‐Yun Lai, Hongxia Shi, (unknown), Xiaohui Zhang, Lan‐Ping Xu, Yu Wang, Qian Jiang, Xiao‐Jun Huang, Ying‐Jun Chang	0
6	Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysis 2023 ·Frontiers in Immunology ·(unknown), (unknown), Liping Dou, Yanmin Zhao, Xiaohui Zhang, Lan‐Ping Xu, Yu Wang, Xiao‐Jun Huang, Xiao‐Dong Mo	11
7	Basiliximab is the potential solution for severe liver chronic GVHD: A prospective pilot study 2023 ·(unknown), (unknown), Xiaohui Zhang, Lan‐Ping Xu, Yu Wang, Chen‐Hua Yan, Yu‐Hong Chen, Huan Chen, Wei Han, Feng‐Rong Wang, Jingzhi Wang, Xiao‐Jun Huang, Xiao‐Dong Mo	8
8	Spotlight on iron overload and ferroptosis: Research progress in female infertility 2023 ·Life Sciences ·Jinghua Zhang, (unknown), Yuan Fan, Cheng Cheng, Lan‐Ping Xu, (unknown)	17
9	[Clinical analysis of the usefulness of letermovir for prevention of cytomegalovirus infection after haploidentical hematopoietic stem cell transplantation]. 2023 ·PubMed ·Rui Ma, Yi He, (unknown), Lu Bai, Wei Han, Yifei Cheng, K Y Liu, Lan‐Ping Xu, (unknown), Y Wang, Ying Zhang, (unknown), Xiao‐Dong Mo, Yan Chen, Xiao‐Jun Huang, Yuqian Sun	2
10	Thrombopoietin level predicts the response to avatrombopag treatment for persistent thrombocytopenia after haploidentical haematopoietic stem cell transplantation 2023 ·Bone Marrow Transplantation ·Hai‐Xia Fu, Meng Lv, Huixin Liu, Yuqian Sun, Yuanyuan Zhang, Xiao‐Dong Mo, Ting‐Ting Han, Feng‐Rong Wang, Chen‐Hua Yan, Yu Wang, Jun Kong, Wei Han, Huan Chen, Yao Chen, Yu‐Hong Chen, Lan‐Ping Xu, Kai‐Yan Liu, (unknown), Xiaohui Zhang	1
11	Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment 2022 ·Cancer Communications ·Chen‐Hua Yan, Yu Wang, Yuqian Sun, Yifei Cheng, Xiao‐Dong Mo, (unknown), (unknown), (unknown), (unknown), Huan Chen, Lan‐Ping Xu, Xiaohui Zhang, Kai‐Yan Liu, Xiao‐Jun Huang	11
12	Pre‐transplantation cytoreduction does not benefit advanced myelodysplastic syndrome patients after myeloablative transplantation with grafts from family donors 2021 ·Cancer Communications ·Yuqian Sun, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Chen‐Hua Yan, Jian Jin, Xiao‐Jun Huang, Yu Wang	3
13	All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP 2021 ·Blood ·Yejun Wu, Hui Liu, Qiaozhu Zeng, Yi Liu, Jingwen Wang, Wensheng Wang, (unknown), (unknown), Qiu-Sha Huang, (unknown), Hai‐Xia Fu, Xiaolu Zhu, Jiang Qian, Hao Jiang, Ying‐Jun Chang, Lan‐Ping Xu, Xiao‐Jun Huang, Xiaohui Zhang	11
14	Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation 2021 ·Bone Marrow Transplantation ·Jin Wu, Hai‐Xia Fu, (unknown), Xiao‐Dong Mo, Xiao Liu, (unknown), (unknown), Huixin Liu, Chen‐Hua Yan, Yu‐Hong Chen, Ying‐Jun Chang, Lan‐Ping Xu, Kai‐Yan Liu, Xiao‐Jun Huang, Xiaohui Zhang	10
15	Monocyte subsets in bone marrow grafts may contribute to a low incidence of acute graft‐vs‐host disease for young donors 2020 ·Journal of Cellular and Molecular Medicine ·Qi Wen, Hongyan Zhao, (unknown), Yuanyuan Zhang, Hai‐Xia Fu, Yu Wang, Lan‐Ping Xu, Xiaohui Zhang, Yuan Kong, Xiao‐Jun Huang	5
16	[Clinical significance of monitoring ETV6-RUNX1 fusion gene expression in children with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation]. 2017 ·PubMed ·Yang Hong, (unknown), Yan Xu, (unknown), (unknown), Lan‐Ping Xu, (unknown), Xiao‐Jun Huang, Xiaosu Zhao	0
17	Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study 2016 ·Clinical Cancer Research ·Yu Wang, Qifa Liu, Lan‐Ping Xu, Kai‐Yan Liu, Xiaohui Zhang, Xiao Ma, Meiqing Wu, Depei Wu, Xiao‐Jun Huang	115
18	Chimeric antigen receptors T cells as second line therapy for acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation: high remission rate without causing graft versus host disease 2016 ·Yuhong Chen, Lan‐Ping Xu, Huan Chen, Yao Chen, Xiao‐Dong Mo, Yuanyuan Zhang, Xiaohui Zhang, Kai‐Yan Liu, Aidong Lu, (unknown), Jingbo Wang	1
19	Interferon-α: A Potentially Effective Treatment for Minimal Residual Disease in Acute Leukemia/Myelodysplastic Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation 2015 ·Biology of Blood and Marrow Transplantation ·Xiao‐Dong Mo, Xiaohui Zhang, Lan‐Ping Xu, Yu Wang, Chen‐Hua Yan, Huan Chen, Yu‐Hong Chen, Wei Han, Feng‐Rong Wang, Jingzhi Wang, Kai‐Yan Liu, Xiao‐Jun Huang	46
20	Allogeneic hematopoietic stem cell transplantation for the treatment of chronic myeloid leukemia in the era of tyrosine kinase inhibitors 2013 ·Chinese Medical Journal ·Lan‐Ping Xu, Xiao‐Jun Huang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact